Reassessing beta blocker use after heart attack

Image credit: joshua_chehov via Unsplash

Recent studies suggest that the routine use of beta blockers after a heart attack may not be necessary for all patients. Researchers found that these drugs, commonly used to slow heart rate and lower blood pressure, showed no clear benefit for patients whose hearts were still functioning well. The findings point to the potential value of tailoring treatment to individual patient needs rather than applying a one-size-fits-all approach.

Source

Javed Butler, Francesco Fioretti, Ciaran J McMullan, Kevin J Anstrom, Irina Barash, Marc P Bonaca, Maria Borentain, Stefano Corda, Pedro P Teixeira, Justin A Ezekowitz, Davis Gates, Carolyn S P Lam, Eldrin F Lewis, JoAnn Lindenfeld, Robert J Mentz, Christopher M O’Connor, Piotr Ponikowski, Yogesh N V Reddy, Giuseppe M C Rosano, Clara Saldarriaga, Michele Senni, James Udelson, Alessia Urbinati, Vanja Vlajnic, Adriaan A Voors, Aiwen Xing, Mahesh J Patel, Faiez Zannad, VICTOR Study Group, Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial, European Heart Journal, 2025;, ehaf655, https://doi.org/10.1093/eurheartj/ehaf655

Additional Reading:

https://abcnews.go.com/Health/doctors-rethink-decades-routine-beta-blocker-patients-after/story?id=125112970

https://www.cnn.com/2025/08/30/health/heart-attack-beta-blockers-wellness#:~:text=A%20class%20of%20drugs%20called,according%20to%20groundbreaking%20new%20research.

https://www.mountsinai.org/about/newsroom/2025/beta-blockers-the-standard-treatment-after-a-heart-attack-may-offer-no-benefit-for-heart-attack-patients-and-women-can-have-worse-outcomes